December 22, 2014 1:34 AM ET

Pharmaceuticals

Company Overview of MiniVax, Inc.

Company Overview

MiniVax, Inc. engages in the research and development of vaccines and therapeutics for the treatment and prevention of opportunistic fungal infections. It focuses on developing solutions for the indication Pneumocystis pneumonia (PCP), such as PCP-Antibody, a monoclonal antibody for the treatment of PCP; PCP-Vaccine, a vaccine that promotes the development of long-term anti-Pneumocystis antibodies for the prevention of PCP; and PCP-Diagnostic, a diagnostic solution for the detection of a Pneumocystis infection. The company was incorporated in 2010 and is based in New Orleans, Louisiana.

1441 Canal Street

Suite 314

New Orleans, LA 70112

United States

Founded in 2010

Phone:

504-264-2829

Fax:

504-324-0686

Key Executives for MiniVax, Inc.

Chairman and Chief Executive Officer
Chief Operating Officer
Senior Vice President of Regulatory Affairs and Director
Senior Director of Technical Operations
Treasurer and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Melaleuca, Inc. United States
Candeoo, Inc. United States
Pharmacann LLC United States
B.F. Ascher & Company, Inc. United States
Hemophilia Resources of America, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MiniVax, Inc., please visit www.minivaxcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.